Term
| Diphenoxylate/atropine (Lomotil) |
|
Definition
| Opiate/Opiate derivative (Antimotility agent) |
|
|
Term
|
Definition
| Opiate/Opiate derivative (Antimotility agent) |
|
|
Term
|
Definition
|
|
Term
| Bismuth subsalicylate (Pepto Bismol, Kaopectate) |
|
Definition
|
|
Term
|
Definition
| Bacterial replacement (used in diarrhea) |
|
|
Term
|
Definition
|
|
Term
| Methylcellulose (Citrucel) |
|
Definition
|
|
Term
|
Definition
| Stool Softener (Emollients) |
|
|
Term
| Polyethylene glycol (MiraLax) |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| Magnesium hydroxide (Milk of Magnesia) |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| NEW stimulant + Osmotic Laxative |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Chloride channel activator |
|
|
Term
|
Definition
| guanylate cyclase-c agonist |
|
|
Term
| Methylnaltrexone (Relistor) |
|
Definition
| Peripherally acting mu-receptor antagonist |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Highly selective substance-P/neurokinin-1 receptor antagonist |
|
|
Term
|
Definition
|
|
Term
| Prochlorperazine (Compazine) |
|
Definition
|
|
Term
| Scopolamine (Transderm-Scop) |
|
Definition
| antagonizes acetylcholine at muscarinic receptors |
|
|
Term
|
Definition
| Endogenous cannabinoid receptor agonist |
|
|
Term
|
Definition
| H1 antagonist; anticholinergic as well |
|
|
Term
| Dimenhydrinate (Dramamine) |
|
Definition
| 55% diphenhydramine (H1 blocker); Anticholinergic effect |
|
|
Term
|
Definition
| competitive antagonist at ileal 5-HT3 receptors |
|
|
Term
|
Definition
| Pregnancy Category A, Antihistamine |
|
|
Term
| Metronidazole, amoxicillin, tetracycline, and clarithromycin; Bismuth subsalicylate (Pepto-Bismol) and PPIs |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| Dexlansoprazole (Dexilant) |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Histamine-2 Receptor Antagonist |
|
|
Term
|
Definition
| Histamine-2 Receptor Antagonist |
|
|
Term
|
Definition
| Histamine-2 Receptor Antagonist |
|
|
Term
|
Definition
| Histamine-2 Receptor Antagonist |
|
|
Term
|
Definition
| forms a paste-like barrier that adheres to the base of ulcer |
|
|
Term
|
Definition
| synthetic prostaglandin E2 analog that replaces protective prostaglandins |
|
|
Term
|
Definition
|
|
Term
|
Definition
| contain magnesium, aluminum, calcium carbonate, or sodium bicarbonate; buffering agents |
|
|
Term
| Sodium Alginate (Gaviscon) |
|
Definition
| reacts with sodium bicarbonate and saliva to form a viscous solution of sodium alginate |
|
|
Term
|
Definition
| New drug to treat C. Difficile |
|
|
Term
| Ibuprofen, Naproxen, Ketoprofen, Diclofenac potassium, aspirin, acetaminophen/aspirin/caffeine |
|
Definition
| First line therapy; proven efficacy; Migraine Abortive Treatment |
|
|
Term
| Metoclopramide (Reglan) IV: Isometheptene and combinations |
|
Definition
| Antiemetic in Migraine Abortive Treatment |
|
|
Term
|
Definition
| Only agent with consistent migraine relief |
|
|
Term
|
Definition
|
|
Term
|
Definition
5HT(IB/ID) receptor: headache relief; 5HT (2A) receptor: generalized vasoconstriction
(not considered 1st line) |
|
|
Term
|
Definition
| IV or Intranasal; good evidence for safety and efficacy; Contraindicated in Pregnancy |
|
|
Term
|
Definition
| Ergotamine compounds with caffeine; improved absorption and potentiates pain relief properties |
|
|
Term
|
Definition
| DOC preventative migraine therapy |
|
|
Term
|
Definition
| 1st line therapy; good choice for mixed tension/migraine headache |
|
|
Term
|
Definition
| especially useful for pts w/ prolonged or atypical aura |
|
|
Term
|
Definition
| Limited use due to propensity for severe ADRs (migraine prevention) |
|
|
Term
|
Definition
| Delay of 1-2 months for effect (migraine prevention) |
|
|
Term
|
Definition
| Modest efficacy; good choice for menstrual migraines |
|
|
Term
|
Definition
| expensive; dimilar efficacy to propranolol |
|
|
Term
|
Definition
| Best evidence abortive treatment of tension headache |
|
|
Term
|
Definition
| Less effective than NSAIDs; mixed results (abortive treatment of tension headache) |
|
|
Term
| Amitriptyline 75-150 mcg/day |
|
Definition
| DOC preventative for tension headaches (causes weight gain!) |
|
|
Term
|
Definition
| alpha agonist; preventative for tension headaches; used in chronic type |
|
|
Term
| Mirtazapine and Botulinum toxin type A |
|
Definition
| preventative tension headache |
|
|
Term
| ergot compounds (inhalation only) |
|
Definition
| abortive treatment cluster headaches |
|
|
Term
|
Definition
| DOC preventative treatment cluster headaches |
|
|
Term
|
Definition
| Good for short, mild cluster HA periods; DON'T COMBINE with triptans! |
|
|
Term
|
Definition
| quickly reduces number of attacks for episodic type cluster headaches |
|
|
Term
|
Definition
| used for both chronic and episodic cluster headaches |
|
|
Term
| Long acting NSAIDs; Amitriptyline, Nausea medications |
|
Definition
| Prophylactic therapy for Medication Overuse Headache |
|
|
Term
| Albuterol (Cystic Fibrosis) |
|
Definition
| first med used in resp. treatment CF |
|
|
Term
| Hypertonic saline, then Pulmozyme (vest simultaneously) |
|
Definition
| second med used in resp. treatment CF |
|
|
Term
|
Definition
| third med used in resp. treatment CF |
|
|
Term
|
Definition
| fourth med used in resp. treatment CF |
|
|
Term
|
Definition
| mucolytic; breaks up long DNA strands, decreases mucus viscosity |
|
|
Term
|
Definition
| studies show benefit for nutritional status and fewer pulmonary infections; monitor for atypical mycobacterium |
|
|
Term
|
Definition
| Oral antipseudomonal antibiotic |
|
|
Term
| Tobramycin, Cayston, Colistimethate (in CF) |
|
Definition
| inhaled antipseudomonal antibiotic |
|
|
Term
| Penicillins, Cephalosporins, Carbapenems, Tobramycin, Ciprofloxacin, Aztreonam (in CF) |
|
Definition
| IV Antipseudomonal Antibiotics |
|
|
Term
|
Definition
| Stenotrophomonas maltophilia and Burkholderia cepacia |
|
|
Term
|
Definition
| Treats and prevents CF liver disease |
|
|
Term
| Periactin (cyproheptadine) |
|
Definition
|
|
Term
|
Definition
| indicated for CF patients > 6 years old with G441D mutation |
|
|
Term
|
Definition
| CFTR Corrector; facilitates movement of the CFTR protein to the cell surface |
|
|
Term
| Azmacort Aerosol, Intal MDI, Aerobid MDI, Primatene mist, Combivent MDI, Maxair Autohaler |
|
Definition
| Chlorofluorocarbons (CFCs) MDI sunset |
|
|
Term
|
Definition
| not for children < 4 years; limited expiration date once opened |
|
|
Term
|
Definition
| short acting beta 2 agonist inhalation; racemic mixture |
|
|
Term
|
Definition
| short acting beta 2 agonist inhalation |
|
|
Term
|
Definition
| Long acting beta 2 agonist |
|
|
Term
|
Definition
| Long acting beta 2 agonist |
|
|
Term
|
Definition
| competitive inhibition of muscarinic cholinergic receptors; Relief of acute exacerbations; used in addition to short actin beta 2 agonists |
|
|
Term
|
Definition
| Theophyline, aminophyline |
|
|
Term
| Theophyline, aminophyline |
|
Definition
| Altnerative additive long-term therapy (asthma) -- rarely used |
|
|
Term
| Fluticasone/salmeterol (Advair) |
|
Definition
| inhaled corticosteroid + long acting beta agonist |
|
|
Term
| Budesonide/formoterol (Symbicort) |
|
Definition
| inhaled corticosteroid + long acting beta agonist |
|
|
Term
| Mometasone/formoterol (Dulera) |
|
Definition
| inhaled corticosteroid + long acting beta agonist |
|
|
Term
| Cromolyn and Nedocromil (asthma) |
|
Definition
| alternative: long-term therapy; Prophylactic treatment; mast cell stabilizer |
|
|
Term
| Zafirlukast, Montelukast (Zileuton) |
|
Definition
| Alternative long term therapy; Leukotriene inhibitors |
|
|
Term
|
Definition
| long term management for severe asthmatics (additive); persistent allergic asthma; poorly controlled asthma |
|
|
Term
| Brompheniramine, Chlorpheniramine, Clemastine, Diphenhydramine |
|
Definition
| Sedating Systemic Antihistamines |
|
|
Term
| Cetirizine, Fexofenadine, Levocetirizine, Loratadine, Desloratadine |
|
Definition
| Nonsedating Systemic Antihistamines |
|
|
Term
|
Definition
|
|
Term
| Beclomethasone dipropionate (Beconase AQ) |
|
Definition
|
|
Term
|
Definition
|
|
Term
| Pseudoephedrine and phenylephrine |
|
Definition
|
|
Term
| Oxymetazoline, Tetrahydrozoline, Xylometazoline |
|
Definition
| Topical decongestants (more rapid and effective than systemic) |
|
|
Term
|
Definition
| Nasal Mast cell Stabilizer |
|
|
Term
| Azelastine and olopatadine |
|
Definition
| Intranasal Antihistamines |
|
|
Term
|
Definition
| intranasal anticholinergics |
|
|
Term
| Bepotastine, cromolyn, lodoxamide, nedocromil |
|
Definition
| mast cell stabilizers (ophthalmic) |
|
|
Term
|
Definition
|
|
Term
| Alcaftadine, azelastine, epinastine, ketotifen, olopatadine |
|
Definition
| Mastcell stabilizer/antihistamines (ophthalmic) |
|
|
Term
| Naphazoline, oxymetazoline, phenylephrine, tetrahydrorzoline |
|
Definition
|
|
Term
| naphazoline/pheniramine maleate |
|
Definition
| ophthalmic decongestant/antihistamines |
|
|
Term
|
Definition
|
|
Term
| beta blockers, prostaglandin analogs, brimonidine, topical carbonic anhydrase inhibitors |
|
Definition
| 1st line Treatment open-angle glaucoma |
|
|
Term
| pilocarpine, apraclonidine |
|
Definition
| 2nd line treatment - open-angle glaucoma |
|
|
Term
| carbachol, oral carbonic anhydrase inhibitors, echothiophate |
|
Definition
| 3rrd line treatment- open-angle glaucoma |
|
|
Term
| Betaxolol, Carteolol, Levobunolol, Metipranolol, Timolol |
|
Definition
| Beta blockers used in open-angle glaucoma |
|
|
Term
| Latanoprost, Tafluprost, Travoprost solutions |
|
Definition
| Synthetic prostaglandine F2alpha analogues (open angle glaucoma) |
|
|
Term
| Bimatoprost 0.03% (latisse, allergan) |
|
Definition
|
|
Term
| Apraclonide, Brimonidine, Brimonidine and Timolol |
|
Definition
| Adrenergic Agonists-selective for open-angle glaucoma |
|
|
Term
| Brinzolamide, dorzolamide, dorzolamide and timiolol |
|
Definition
| Carbonic anhydrase inhibitors (1st line; open angle glaucoma) |
|
|
Term
| carbachol and pilocarpine |
|
Definition
| cholinergic agonists direct acting (open angle glaucoma) |
|
|
Term
|
Definition
| cholinesterase inhibitors (open angle glaucoma) |
|
|
Term
| ilocarpine, hyperosmotic, secretory inhibitor |
|
Definition
| used for Treatment (acute attack of closed-angle glaucoma) |
|
|
Term
| Antioxidant vitamins and minerals |
|
Definition
| treatment dry form macular degeneration |
|
|
Term
|
Definition
| cytotoxic photosensitizing agent; treatment in wet form macular degeneration |
|
|
Term
| Vascular endothelial growth factor inhibtors |
|
Definition
| Aflibercept, pegaptanib, ranibizumab, bevacizumab--- injections for wet form macular degeneration |
|
|
Term
|
Definition
| treatment in wet form macular degeneration |
|
|
